BioTech Medics Inc BMCS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BMCS is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.03
- Day Range
- $0.02–0.03
- 52-Week Range
- $0.00–0.05
- Bid/Ask
- $0.02 / $0.03
- Market Cap
- $3.87 Mil
- Volume/Avg
- 13,100 / 36,557
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
BioTech Medics Inc is a medical-based holding company. The company operates through four divisions namely Medical, Nutraceutical Products, Sports Medicine, and Research and Development.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- http://www.biotecmedics.com
Valuation
|
Metric
|
BMCS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BMCS
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
BMCS
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Dnvgf | $82.2 Bil | |
MKKGY
| Merck KGaA ADR | Tzgxhv | $75.8 Bil | |
HLN
| Haleon PLC ADR | Gzch | $38.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Drkqh | $11.5 Bil | |
VTRS
| Viatris Inc | Pttt | $11.2 Bil | |
CTLT
| Catalent Inc | Mfqnj | $7.2 Bil | |
PRGO
| Perrigo Co PLC | Qfgb | $4.2 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wwrrhhr | $2.9 Bil | |
CURLF
| Curaleaf Holdings Inc | Gzxy | $2.6 Bil | |
GTBIF
| Green Thumb Industries Inc | Mpmmb | $2.5 Bil |